dabigatran fda approval 2010

FDA Safety Changes: Dabigatran Linked With Bleeding Risk.

Today's Hospitalist :: Dabigatran receives FDA approval.
Dabigatran Approved! Now How Do We Use It? - Medscape.
May 31, 2011. Based largely on these findings, the US Food and Drug Administration in October 2010 approved dabigatran for the prevention of stroke and .
Oct 19, 2010. Today, the FDA approved the first new anticoagulant in fifty years, dabigatran ( marketed by Boehringer Ingelheim Pharmaceuticals Inc. under .
Jun 3, 2013. Pradaxa-Packages When the FDA first approved the anticoagulant Pradaxa on October 19, 2010, the move was considered a “major .
Sep 20, 2010. Dabigatran etexilate is a new drug in development for stroke. Update: Pradaxa ( dabigatran etexilate) Now FDA Approved .. FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation - October 19, 2010.
FDA pregnancy category C. It is not known whether Pradaxa will harm an unborn baby. Tell your doctor if you .. Approval History FDA approved 2010. Close.
Dec 19, 2012. Pradaxa users were more likely to experience strokes, heart attacks. 2011 Safety Alerts for Human Medical Products · 2010 Safety Alerts for. ISSUE: The U.S. Food and Drug Administration (FDA) is informing. Pradaxa is not approved for patients with atrial fibrillation caused by heart valve problems.
Dabigatran: A Revolutionary Blood-Thinning Drug - CBS News.

FDA Approves Pradaxa to Prevent Stroke in People With Atrial.

Pradaxa (dabigatran etexilate mesylate) - New FDA Drug Approval.

FDA Warning Pradaxa Side Effects - Wrongful Death.

Mar 13, 2013. The drug was approved by the FDA in October 2010, as an alternative to. “We were concerned that postmarketing use of dabigatran might be .
The pills were approved for use in the U.S. in October of 2010 and gained. FDA Safety Information 2012: Pradaxa (dabigatran etexilate mesylate) capsules.
Dabigatran wins FDA approval: Alternative to warfarin? - IPRO Blogs.
May 31, 2011. Based largely on these findings, the US Food and Drug Administration in October 2010 approved dabigatran for the prevention of stroke and .
Oct 19, 2010. Today, the FDA approved the first new anticoagulant in fifty years, dabigatran ( marketed by Boehringer Ingelheim Pharmaceuticals Inc. under .